Live Breaking News & Updates on Servicios De Alta Tecnolog
Stay updated with breaking news from Servicios de alta tecnolog. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Enhancing GISRS Respiratory Disease Surveillance in Americas with Genetic Characterization Training miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Latin American and Caribbean research contributions to tackle challenges posed by brain diseases Every year there are nearly ten million new cases of dementia globally, of which Alzheimer s Disease (AD) is the most common form, accounting for around 60-70% of cases. This special supplement, published in the Journal of Alzheimer s Disease, focuses on the challenges posed by brain disease and presents significant research contributions from Latin America and the Caribbean that address these challenges to help improve the lives of individuals with AD. AD is a complex, multifactorial neurodegenerative disorder that represents a major and increasing global health challenge. Neuroscience is making strides in unraveling the brain s secrets through translational research and drug discovery in order to improve the lives of individuals with a wide variety of neurological and psychiatric disorders such as AD, Parkinson s disease, schizophrenia, depression, traumatic brain injury ....
Alphagalileo > Item Display alphagalileo.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alphagalileo.org Daily Mail and Mail on Sunday newspapers.
SANDRO DA MESQUITA Adamaged drainage system in the brain might be behind the spotty performance of some Alzheimer’s therapies, according to a study published April 28 in Nature. Mice modeling the neurodegenerative disorder that received plaque-busting antibodies along with a treatment to stimulate the growth of lymphatic vessels in the brain saw many of their symptoms reversed. Mice with damaged lymphatics, on the other hand, didn’t respond as well to the antibodies. This suggests that dysfunctional lymphatics might hinder the performance of antibody-based immunotherapy, an approach that has had mixed results in clinical trials among Alzheimer’s patients. “Whenever a paper provides us with a novel way to look at Alzheimer’s, such as this one does . . . it opens up a world of possibilities,” says Gabrielle Britton, a neuroscientist at the Instituto de Investigaciones Científicas y Servicios de Alta Tecnología in Panama who was not involved in the resear ....